Crossmark

γ‐Secretase inhibitors in cancer clinical trials are pharmacologically and functionally distinct

Crossref DOI link: https://doi.org/10.15252/emmm.201607265

Published Online: 2017-05-24

Published Print: 2017-07

Update policy: https://doi.org/10.1002/crossmark_policy

Authors

Ran, Yong https://orcid.org/0000-0002-9748-4392
Hossain, Fokhrul

Pannuti, Antonio

Lessard, Christian B

Ladd, Gabriela Z

Jung, Joo In

Minter, Lisa M

Osborne, Barbara A

Miele, Lucio

Golde, Todd E https://orcid.org/0000-0003-1867-7071
Funding

Funding for this research was provided by:

National Cancer Institute (1P01CA166009 01A1)

National Institute on Aging (2P01 AG020206)
License Information

Version of Record valid from 2017-05-24
More Information

Publication History

Received: 2016-10-27

Accepted: 2017-04-25

Published: 2017-05-24